-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
LENZ Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
- LENZ Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$16.1 M, a 27.5% decline year-over-year.
- LENZ Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$139 M, a 50.2% decline year-over-year.
- LENZ Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$135 M, a 28% decline from 2022.
- LENZ Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$106 M, a 74.8% decline from 2021.
- LENZ Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$60.4 M, a 348% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)